Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

Phase 3 N=234 Efficacy and Safety of Primovist in Chinese Patients

Known or Suspected Focal Liver Lesions
Primary: Difference in Sensitivity of Lesion Detection in MRI Images (Post-contrast MRI Minus Pre-contrast MRI) Measured as Percentage Points — 8.65; 12.23; 7.50 Percentage points
Bayer Results Dec 2009 0.0% serious AE View details

N/A N=60 Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study

Non-Alcoholic Fatty Liver Disease · Non-Alcoholic Steatohepatitis
Primary: Correlation of the Liver Fat Percentage Reported From MRI-PDFF With Measurements Hepatorenal Index (HRI) of Ultrasound Biomarkers for Liver Fat. — 1.6 Hepatorenal Index
Philips Clinical & Medical Affairs Global Results Jan 2026 0.0% serious AE View details

Phase 4 N=96 Hepatic Xenetix-CT Perfusion

Hepatocellular Carcinoma
Primary: Blood Volume (BV) According to Degree of Lesions Differentiation — 15.930; 13.958 mL/100 grams
Guerbet Results Jul 2017 0.0% serious AE View details

N/A N=30 Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study

Non-Alcoholic Fatty Liver Disease · Non-Alcoholic Steatohepatitis
Primary: Correlation of the Liver Fat Percentage Reported From MRI-PDFF With Measurements of Hepatorenal Index (HRI) Ultrasound Biomarker for Liver Fat. — 1.7 Hepatorenal Index
Philips Clinical & Medical Affairs Global Results Jan 2026 0.0% serious AE View details

N/A N=27 PET/CT-Assessment of Liver Tumor Ablation

Liver Tumor · Liver Neoplasms
Primary: Number and Percentage of Tumors With Complete, Circumferential Ablation Margin Visibility During FDG PET/CT-guided Liver Ablations (AP-PET-1 v. Contrast-enhanced MRI)…
Dana-Farber Cancer Institute Results Mar 2020 0.0% serious AE View details